| HOME >> MEDICINE >> TECHNOLOGY |
$
565$
-$
2,820$
,350 Licensing fees
6456782,6382,527 Product sales and other
1617612,773 Total revenues
1,2266955,5196,650Cost of product sales
4761485842,597 Gross profit
7505474,9354,053Operating expenses: Research and development
6,9092,69023,1379,631 Selling, general and administrative
7,1137,18527,68531,571 Depreciation and amortization
1,2391,5174,5824,009 Total operating expenses
15,26111,39255,40445,211 Operating loss
(14,511)(10,845)(50,469)(41,158)Interest expense
5722702,120511Interest income
(22)(67)(124)(399)Other income
(200)(503)(163)(588) Net loss
$ (14,861)$
(10,545)$ (52,302)$ (40,682)Loss per share:Basic and diluted loss per share
$
(0.21)$
(0.17)$
(0.78)$
(0.70)UNILIFE CORPORATION AND SUBSIDIARIESReconciliation of Non-GAAP Measure(unaudited)Three Months Ended
June 30,Year Ended
June 30,2012201120122011(in thousands, except per share amounts)Net loss
$ (14,861)$
(10,545)$ (52,302)$ (40,682)Share-based compensation expense
2,0982,4207,8869,022Depreciation and amortization
1,2391,5174,5824,009Interest expense
5722702,120511Adjusted net loss
$ (10,952)$
(6,338)$
(37,714)$ (27,140)Adjusted net loss per share - diluted
$
(0.15)$
(0.10)$
(0.56)$
(0.47)
| SOURCE Unilife Corporation Copyright©2012 PR Newswire. All rights reserved |